New Leaf Venture Partners is a leader in healthcare technology venture investing. They focus primarily on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies.
Phone: 646-871-6400
7 Times Square
Suite 3502
New York, 10036
New York, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-05-07 | Neurana Pharmaceuticals | Series A | $60M | H.I.G. BioHealth Partners, Longitude Capital, MagnaSci Ventures, and Sofinnova Ventures |
| 2018-04-25 | Rallybio | Series A | $37M | 5AM Ventures, Canaan Partners, and Connecticut Innovations |
| 2018-04-18 | Kyruus | Series F | $9.99M | F-Prime Capital, Highland Capital Partners, Leerink Partners, Lux Capital, McKesson, Providence Ventures, and Venrock |
| 2018-04-04 | Arvinas | Series C | $55M | 5AM Ventures, Canaan Partners, Deerfield Management, Hillhouse Capital Management, Nextech Invest, OrbiMed Advisors, RA Capital Management, and Sirona Capital |
| 2017-12-18 | Aptinyx | Series B | $70M | Adage Capital Management, Adams Street Partners, Agent Capital, Bain Capital, Beecken Petty O'Keefe & Company, Frazier Healthcare, Goudy Park Capital, HBM Healthcare Investments, Longitude Capital, LVP, Nan Fung, Northwestern University, Osage University Partners, Partner Fund Management, PathoCapital, and Rock Springs Capital |
